Literature DB >> 1726164

Antibodies against hepatitis C virus in mixed cryoglobulinemia patients.

C Ferri1, F Greco, G Longombardo, P Palla, A Moretti, E Marzo, P V Fosella, G Pasero, S Bombardieri.   

Abstract

The prevalence of antibodies against hepatitis C virus (anti-HCV) in an unselected series of 45 mixed cryoglobulinemia patients was assessed by an enzyme linked immunosorbent assay (Chiron ELISA HCV, Second Generation). The anti-HCV specificity was evaluated by a recombinant based immunoblot assay (Chiron RIBA HCV, Second Generation Assay). HBV-related markers and HIVAb were detected in the same samples. The prevalence of anti-HCV observed in mixed cryoglobulinemia was compared with 80 patients with other immunological systemic diseases. Anti-HCV were found in 91% of mixed cryoglobulinemia patients, and confirmed by RIBA in all cases; on the other hand, anti-HCV were practically absent in other control diseases. HBV markers were recorded in 49% of mixed cryoglobulinemia subjects; while HIVAb were constantly absent. These data give us new insights into the etiopathogenesis of mixed cryoglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726164     DOI: 10.1007/bf01726453

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Hepatitis C virus in patients with cryoglobulinemia type II.

Authors:  M Pascual; L Perrin; E Giostra; J A Schifferli
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia.

Authors:  C Ferri; M Pietrogrande; R Cecchetti; A Tavoni; A Cefalo; G Buzzetti; C Vitali; S Bombardieri
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

3.  Clinical conference: Mixed cryoimmunoglobulinemia.

Authors: 
Journal:  Am J Med       Date:  1976-07       Impact factor: 4.965

4.  Association between hepatitis B virus and essential mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; D Zucker-Franklin; E C Franklin
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

5.  Antibodies to hepatitis C virus in Italian blood donors.

Authors:  G Sirchia; A Bellobuono; A Giovanetti; M Marconi
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

6.  Cryoglobulins and immune complexes in essential mixed cryoglobulinemia.

Authors:  S Bombardieri; C Ferri; P Migliorini; A Pontrandolfo; A Puccetti; C Vitali; G Pasero
Journal:  Ric Clin Lab       Date:  1986 Apr-Jun

7.  Hepatitis B virus and essential mixed cryoglobulinaemia.

Authors:  M Galli; F Careddu; A D'Armino; G Monti; K Messina; F Invernizzi
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

8.  Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement.

Authors:  C Ferri; G Gremignai; S Bombardieri; L Moriconi; A Pontrandolfo; C Vitali; P V Fosella; G Pasero
Journal:  Ric Clin Lab       Date:  1986 Apr-Jun

9.  Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.

Authors:  J W Popp; J L Dienstag; J R Wands; K J Bloch
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

Review 10.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  11 in total

1.  Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial.

Authors:  C Ferri; E Marzo; G Longombardo; L La Civita; F Lombardini; D Giuggioli; R Vanacore; A M Liberati; A Mazzoni; F Greco
Journal:  Gut       Date:  1993       Impact factor: 23.059

2.  Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients.

Authors:  C Ferri; A L Zignego; G Longombardo; M Monti; L La Civita; F Lombardini; F Greco; A Mazzoni; G Pasero; P Gentilini
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

3.  The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

Authors:  K Ueda; H Nakajima; T Nakagawa; A Shimizu
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 4.  The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.

Authors:  Franco Dammacco; Vito Racanelli; Sabino Russi; Domenico Sansonno
Journal:  Clin Exp Med       Date:  2016-03-02       Impact factor: 3.984

Review 5.  An approach to the diagnosis and management of systemic vasculitis.

Authors:  A Miller; M Chan; A Wiik; S A Misbah; R A Luqmani
Journal:  Clin Exp Immunol       Date:  2010-01-12       Impact factor: 4.330

Review 6.  A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha.

Authors:  C A Schirren; R Zachoval; C G Schirren; A L Gerbes; G R Pape
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

Review 7.  Kidney disease in patients with chronic hepatitis C.

Authors:  M Philipneri; B Bastani
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 8.  The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.

Authors:  Franco Dammacco; Gianfranco Lauletta; Angelo Vacca
Journal:  Clin Exp Med       Date:  2022-03-28       Impact factor: 5.057

Review 9.  Symptomatic cryoglobulinemia.

Authors:  A Dispenzieri
Journal:  Curr Treat Options Oncol       Date:  2000-06

Review 10.  Viruses, virulence and pathogenicity.

Authors:  J Hibbs; N S Young
Journal:  Baillieres Clin Haematol       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.